An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.

PHASE3CompletedINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

March 31, 2006

Conditions

Migraine

Interventions

DRUG

topiramate

All Listed Sponsors

collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210860 - An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention. | Biotech Hunter | Biotech Hunter